Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Net Income (Common)
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Z
|
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
|
Net Income (Common)
¥697.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
29%
|
CAGR 10-Years
16%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥4.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Net Income (Common)
¥3.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
23%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥6.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
4%
|
CAGR 10-Years
15%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥4.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Net Income (Common)
¥311.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Glance View
Founded in 1973, Zhejiang Jiuzhou Pharmaceutical Co. Ltd. has steadily navigated the evolving tides of the global pharmaceutical industry with a compelling blend of innovation and traditional business acumen. Rooted in China's dynamic Zhejiang province, the company initially focused on manufacturing basic pharmaceutical intermediates. Over the years, it strategically expanded its operations, becoming a key player in both the Active Pharmaceutical Ingredients (APIs) and Contract Development and Manufacturing Organization (CDMO) sectors. This dual focus has allowed Jiuzhou Pharmaceutical to innovate and offer comprehensive services, ranging from drug development to commercial manufacturing, effectively appealing to a broad range of customers including some of the world's leading pharmaceutical companies. At the heart of Jiuzhou Pharmaceutical's success lies its commitment to research and development, a cornerstone that supports its diversification strategy. The company leverages its extensive expertise and cutting-edge technology to improve existing drugs while also participating in the development of new, patented pharmaceuticals. By fostering strong partnerships with global pharmaceutical giants, Jiuzhou effectively integrates itself into the larger pharmaceutical ecosystem, providing customized solutions that resonate with market demand. This business model not only reinforces its financial growth but also establishes Zhejiang Jiuzhou as an indispensable contributor to advancements in medicine, continually enhancing its reputation on the international stage.
See Also
What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
697.4m
CNY
Based on the financial report for Sep 30, 2024, Zhejiang Jiuzhou Pharmaceutical Co Ltd's Net Income (Common) amounts to 697.4m CNY.
What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
16%
Over the last year, the Net Income (Common) growth was -39%. The average annual Net Income (Common) growth rates for Zhejiang Jiuzhou Pharmaceutical Co Ltd have been 4% over the past three years , 29% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet